Guerra Pan Advisors LLC Sells 520 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Guerra Pan Advisors LLC reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,448 shares of the exchange traded fund’s stock after selling 520 shares during the period. Guerra Pan Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $665,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Resources Management Corp CT ADV grew its stake in SPDR S&P Biotech ETF by 1,715.8% during the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after buying an additional 326 shares during the last quarter. Tyler Stone Wealth Management bought a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $33,000. EPG Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF by 152.7% during the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after purchasing an additional 278 shares in the last quarter. Compass Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $34,000. Finally, Fortis Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth $38,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock traded down $0.34 during trading hours on Tuesday, hitting $86.01. 5,813,257 shares of the company’s stock were exchanged, compared to its average volume of 11,634,489. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The stock has a market cap of $6.68 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. The stock’s 50-day moving average is $93.95 and its 200-day moving average is $84.04.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.